(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

STEMGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

STEMGEN

ST13

US500000079037493

Class

42

Filing

79037493

Registration

3602603

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

01/08/2020

Trademark type

Combined

Nice classes

42

Filing date

12/18/2006

Registration date

04/07/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/10/2019

Last transaction

04/10/2019

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Milano, IT

Examiner

PERKINS, ELLEN

Law office

M10

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the fancy word "stemgen" in which the letter "s" is comprised in an ellipse which bears an upper sphere, the sign "gen" is slightly shaded with respect to the sign "stem", and a line is drawn immediately under the sign "temgen".

Holders and representatives

Holders

Stemgen S.p.A.
Stemgen S.p.A.

Representatives

Nancy Sabarra FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Services in the field of science and technologyclinical research in the field of brain oncology and degenerative diseases and computer technology associated therewith; scientific medical and pharmacological research services in the field of brain oncologyexcluding pharmaceutical research concerning blood cell production; research and development services in the field of biotechnology in the area of DNA and recombinant proteins; research and technology consultation services regarding diagnostic methods applied to brain oncology and degenerative diseases

Publications

History of USPTO decisions and trademark events.

50 publications found

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

01/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/10/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/10/2019

71AG

REGISTERED-SEC.71 ACCEPTED

04/10/2019

ES71

TEAS SECTION 71 RECEIVED

03/26/2019

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/07/2018

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

05/23/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/09/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2017

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

04/02/2015

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

04/02/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/01/2015

ES75

TEAS SECTION 71 & 15 RECEIVED

03/24/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/11/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/22/2009

FIMP

FINAL DISPOSITION PROCESSED

07/22/2009

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/07/2009

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/01/2009

PLGL

ASSIGNED TO PARALEGAL

06/25/2009

ES7R

TEAS SECTION 7 REQUEST RECEIVED

05/18/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

04/07/2009

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

02/27/2009

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/14/2008

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/11/2008

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/30/2008

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/30/2008

PUBO

PUBLISHED FOR OPPOSITION

10/14/2008

NPUB

NOTICE OF PUBLICATION

09/24/2008

CNEA

EXAMINERS AMENDMENT MAILED

09/12/2008

CRML

CORRESPONDENCE MAILED

09/12/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/11/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/11/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

09/11/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/11/2008

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/10/2008

DOCK

ASSIGNED TO EXAMINER

05/05/2008

CNFR

FINAL REFUSAL MAILED

03/10/2008

CNFR

FINAL REFUSAL WRITTEN

03/07/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

12/27/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/27/2007

ALIE

ASSIGNED TO LIE

12/21/2007

MAIL

PAPER RECEIVED

11/13/2007

RFNT

REFUSAL PROCESSED BY IB

06/29/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/08/2007

RFRR

REFUSAL PROCESSED BY MPU

06/08/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/07/2007

CNRT

NON-FINAL ACTION WRITTEN

06/06/2007

DOCK

ASSIGNED TO EXAMINER

06/04/2007

NWAP

NEW APPLICATION ENTERED

06/04/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/31/2007

Continuous trademark protection

Get notified about every new filing that threatens STEMGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.